An FDA approval of Merck’s drug clesrovimab by June would give physicians another option for protecting newborns from respiratory syncytial virus.

Between April and the end of October, shares kept falling in value, reaching a value of ~$3.5 - down >60%, before Immunity's announcement that it had initiated a first clinical study of a CAR-NK ...

Adding pickled almonds to your winter diet not only enhances flavour but also supports digestion, strengthens immunity, and keeps you warm and active during the colder months.

ImmunityBio shares lost a third of their value Wednesday after the company shared pricing for its public offering. Shares fell 32.2% to $3.15 in recent trading. The stock had fallen about 43.8% ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side ...

(RTTNews) - ImmunityBio, Inc. (IBRX), an immunotherapy company, on Wednesday priced its previously announced underwritten public offering of 33.333 million shares at $3 per share for gross ...

CULVER CITY, Calif., December 11, 2024--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced the pricing of its previously announced underwritten ...

CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced the pricing of its previously announced underwritten public offering of an ...

Jefferies and Piper Sandler acted as joint book running managers for the offering. Pick the best stocks and maximize your portfolio: Published first on TheFly – the ultimate source for real-time ...

CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced the pricing of its previously announced underwritten public offering of an ...

ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced the pricing of its previously announced underwritten public offering of an aggregate of 33,333,334 shares of its ...